New ScientistFirst results from US CRISPR gene editing on human embryosNew ScientistShoukhrat Mitalipov at Oregon Health and Science University and his colleagues used CRISPR to target a genetic mutation that causes thickening of the heart wall. The di… Continue reading
NPR |
In Breakthrough, Scientists Edit a Dangerous Mutation From Genes in Human Embryos
New York Times “We were so surprised that we just couldn’t get this template that we made to be used,” said Shoukhrat Mitalipov, director of the Center for Embryonic Cell and Gene Therapy at Oregon Health and Science University and senior author of the study. “It was … Scientists Precisely Edit DNA In Human Embryos To Fix A Disease GeneNPR Gene editing fixes harmful mutation in human embryosCBS News US scientists fix disease genes in human embryos for 1st timeUSA TODAY CNN –Aljazeera.com –MIT Technology Review –Nature all 446 news articles » |
Nature.com |
CRISPR fixes disease gene in viable human embryos
Nature.com An international team of researchers has used CRISPR–Cas9 gene editing — a technique that allows scientists to make precise changes to genomes with relative ease — to correct a disease-causing mutation in dozens of viable human embryos. The study … |
|
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood …
Markets Insider LONDON, Aug. 2, 2017 /PRNewswire/ — Based on its recent analysis of the blood purification market, Frost & Sullivan recognizes CytoSorbents Corporation with the 2017 Global Frost & Sullivan Award for Product Leadership. CytoSorbents’ deceptively … |
|
Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th
Markets Insider … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. |
|
Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th
Markets Insider … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. |